Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy

PURPOSE: Immunotherapy against immune checkpoints has significantly improved survival both in metastatic and adjuvant setting in several types of cancers. Thyroid dysfunction is the most common endocrine adverse event reported. Patients who are at risk of developing thyroid dysfunction remain to be...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocrinol Invest
Main Authors: Brilli, L., Danielli, R., Campanile, M., Secchi, C., Ciuoli, C., Calabrò, L., Pilli, T., Cartocci, A., Pacini, F., Di Giacomo, A. M., Castagna, M. G.
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2020
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285335/
https://ncbi.nlm.nih.gov/pubmed/33367977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40618-020-01480-6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares